Medicine Man Technologies, Inc. (SHWZ)
OTCMKTS
· Delayed Price · Currency is USD
0.0200
-0.0001 (-0.25%)
Apr 24, 2025, 10:28 AM EDT
Medicine Man Technologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 174.62 | 172.23 | 159.07 | 108.2 | 22.51 | 10.59 | Upgrade
|
| Other Revenue | 0.29 | 0.22 | 0.3 | 0.23 | 1.49 | 0.03 | Upgrade
|
| Revenue | 174.91 | 172.45 | 159.38 | 108.42 | 24 | 10.62 | Upgrade
|
| Revenue Growth (YoY) | 5.55% | 8.20% | 47.00% | 351.74% | 126.03% | 34.00% | Upgrade
|
| Cost of Revenue | 106.9 | 96.42 | 79.09 | 59.07 | 17.23 | 7.62 | Upgrade
|
| Gross Profit | 68.01 | 76.02 | 80.29 | 49.35 | 6.77 | 3 | Upgrade
|
| Selling, General & Admin | 77.79 | 67.36 | 56.75 | 33.91 | 21.45 | 9.19 | Upgrade
|
| Operating Expenses | 78.98 | 70.93 | 59.42 | 38.94 | 29.68 | 16.62 | Upgrade
|
| Operating Income | -10.97 | 5.09 | 20.87 | 10.41 | -22.9 | -13.61 | Upgrade
|
| Interest Expense | -33.13 | -32.07 | -30.14 | -7.01 | -0.04 | -0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.55 | 15.94 | 18.44 | 15.06 | 1.3 | -3.77 | Upgrade
|
| EBT Excluding Unusual Items | -37.55 | -11.04 | 9.17 | 18.46 | -21.65 | -17.55 | Upgrade
|
| Impairment of Goodwill | -1.8 | -1.8 | -8.01 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.37 | 0 | -0.04 | 0.22 | -0.13 | -1.79 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.97 | -1.97 | -4.68 | 0.24 | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | - | 1.78 | Upgrade
|
| Other Unusual Items | - | - | - | - | 1.46 | - | Upgrade
|
| Pretax Income | -41.69 | -14.81 | -3.57 | 18.92 | -20.32 | -17.56 | Upgrade
|
| Income Tax Expense | 17.99 | 19.74 | 14.9 | 4.4 | -0.9 | -0.58 | Upgrade
|
| Net Income | -59.68 | -34.55 | -18.47 | 14.52 | -19.42 | -16.98 | Upgrade
|
| Preferred Dividends & Other Adjustments | 8.19 | 8.15 | 7.8 | 7.35 | - | - | Upgrade
|
| Net Income to Common | -67.86 | -42.7 | -26.27 | 7.17 | -19.42 | -16.98 | Upgrade
|
| Shares Outstanding (Basic) | 74 | 65 | 54 | 43 | 41 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 74 | 65 | 54 | 101 | 41 | 34 | Upgrade
|
| Shares Change (YoY) | 28.04% | 20.32% | -47.09% | 145.94% | 22.16% | 21.50% | Upgrade
|
| EPS (Basic) | -0.91 | -0.66 | -0.49 | 0.17 | -0.47 | -0.50 | Upgrade
|
| EPS (Diluted) | -0.91 | -0.66 | -0.49 | -0.06 | -0.47 | -0.50 | Upgrade
|
| Free Cash Flow | 1.28 | 4.34 | -7.31 | 2.76 | -10.57 | -7.75 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.07 | -0.14 | 0.03 | -0.26 | -0.23 | Upgrade
|
| Gross Margin | 38.88% | 44.09% | 50.38% | 45.52% | 28.23% | 28.27% | Upgrade
|
| Operating Margin | -6.27% | 2.95% | 13.09% | 9.60% | -95.43% | -128.22% | Upgrade
|
| Profit Margin | -38.80% | -24.76% | -16.48% | 6.62% | -80.90% | -159.87% | Upgrade
|
| Free Cash Flow Margin | 0.73% | 2.51% | -4.59% | 2.54% | -44.03% | -73.02% | Upgrade
|
| EBITDA | 11.21 | 26.02 | 31.53 | 18.99 | -22.43 | -13.55 | Upgrade
|
| EBITDA Margin | 6.41% | 15.09% | 19.78% | 17.51% | -93.44% | -127.64% | Upgrade
|
| D&A For EBITDA | 22.18 | 20.93 | 10.66 | 8.58 | 0.48 | 0.06 | Upgrade
|
| EBIT | -10.97 | 5.09 | 20.87 | 10.41 | -22.9 | -13.61 | Upgrade
|
| EBIT Margin | -6.27% | 2.95% | 13.09% | 9.60% | -95.43% | -128.22% | Upgrade
|
| Effective Tax Rate | - | - | - | 23.24% | - | - | Upgrade
|
| Revenue as Reported | 174.91 | 172.45 | 159.38 | 108.42 | 24 | 12.4 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.